bladder cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

bladder cancer
Mar 30, 2025, 21:29 | Insight
Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
Bishoy Morris Faltas, Chief Research Officer at Weill Cornell Medicine, shared a post on LinkedIn:…
Mar 30, 2025, 18:01 | Blog
Philippe Spiess: Always an honor to deliver an update in the management of bladder cancer with Tom Flaig
Philippe Spiess, Assistant Chief of Surgery and Senior Member of the Department of GU Oncology…
Mar 30, 2025, 17:34 | Blog
Olga Kantor: Fantastic presentation by Monika Masanam on MIBC after NST at SSO2025
Olga Kantor, Breast Surgeon at Brigham and Women’s Hospital, shared a post on X: "Fantastic…
Mar 30, 2025, 16:44 | Positive
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on…
Mar 27, 2025, 13:05 | Blog
Mieke Van Hemelrijck: Kicking off Day 1 of the EORTC
Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared a post on…
Mar 27, 2025, 08:00 | Blog
OHMX.bio joins BRECISE to revolutionize prostate and bladder cancer diagnostics
OHMX.bio shared a post on LinkedIn: "OHMX.bio joins BRECISE to revolutionize cancer diagnostics OHMX.bio is…
Mar 26, 2025, 16:43 | Blog
March is Kidney Cancer Awareness Month - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "March is Kidney Cancer Awareness…
Mar 26, 2025, 13:44 | Blog
Laura Bukavina: This is the kind of innovation we need in Bladder Cancer
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared Dmitry Enikeev's,…
Mar 25, 2025, 18:33 | Blog
Roberto Contieri: Great start to EAU 2025 with important session on treatment deintensification in low-grade bladder cancer
Ashish M. Kamat, Professor and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center,…
Mar 25, 2025, 18:07 | Blog
Occupational incidence of bladder cancer amongst veteran ammunition technicians of the British Army
Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared an article by…
Mar 25, 2025, 18:01 | Opinion
Sabine Brookman-May: Panel Discussion on Future of Virus-Like Drug Conjugate AU011 for NMIBC Treatment
Sabine Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences,…
Mar 25, 2025, 09:21 | Blog
Chatbots can empower patients, but they must never replace the human touch: World Bladder Cancer Patient Coalition
World Bladder Cancer Patient Coalition shared a post on Twitter: "'Chatbots can empower patients, but…
Mar 23, 2025, 13:51 | Blog
Highlights from EAU25 by Sabine Brookman-May
The 40th Annual European Association of Urology Congress (EAU25) is happening from March 21 to…
Mar 23, 2025, 08:20 | Blog
Gerben Menschaert: Kick-off of the European BRECISE Project! 
Gerben Menschaert, Co-founder of OHMX bio, posted on LinkedIn: "Kick-off of the European BRECISE Project! …
Mar 22, 2025, 10:34 | Blog
Gianluca Giannarini: Rapid-fire debates bladder cancer at EAU 2025
Gianluca Giannarini, Associate Editor of European Urology, Full Board Member of the EAU Guidelines Office, shared…
Mar 17, 2025, 13:21 | Blog
Sumanta Pal: Second Episode of 'On the Edge of Breakthrough - Voices of Cancer Research' podcasts
Sumanta Pal, Vice Chair of Academic Affairs, Professor and co-director of the Kidney Cancer Program…
Mar 17, 2025, 06:42 | Blog
Matt Campbell: Great bladder cancer session at AtlantaGU25
Matt Campbell, Genitourinary Medical Oncologist at UT MD Anderson Cancer Center, shared a post on…
Mar 16, 2025, 13:04 | Science
Liang Cheng: Interobserver reproducibility of a hybrid three-tier grading system of papillary NMIBC
Liang Cheng, Vice Chair for Translational Research at Warren Alpert Medical School of Brown University…
Mar 14, 2025, 15:22 | Drugs
Enfortumab Vedotin (Padcev): What Patients Need To Know?
Enfortumab vedotin, also known as Padcev, is a groundbreaking antibody-drug conjugate (ADC) designed to treat…
Mar 14, 2025, 13:13 | Drugs
Enfortumab Vedotin (Padcev): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Enfortumab Vedotin, also known as Padcev, is a groundbreaking antibody-drug conjugate (ADC) designed to target…
Mar 12, 2025, 10:44 | Blog
Brandon Luu: A new twin study has strengthened the link between tattoos and cancer risk
Brandon Luu, Resident Physician in Internal Medicine at University of Toronto, shared a post on…
Mar 4, 2025, 05:25 | Blog
Ashish M. Kamat: The 8th edition of Rapid Fire Debates in Bladder Cancer at EAU 2025
Ashish M. Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of…
Feb 25, 2025, 09:48 | Science
Dana-Farber Lank Center for GU Oncology Research Digest for the week of February 15 - 21
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "GU Research Digest for…
Feb 25, 2025, 07:36 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Feb 23, 2025, 05:54 | Cancer Types
Bladder Cancer: Symptoms ,Causes, Stages, Diagnosis and Treatment
Bladder cancer is one of the most common malignancies worldwide, affecting the urinary system and…
Feb 20, 2025, 09:43 | Insight
Neeraj Agarwal: No OS or PFS benefit with SG in pretreated mUC bladder cancer
Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at  Huntsman Cancer Institute, shared a post…
Feb 18, 2025, 19:32 | Blog
Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer
Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura…
Feb 16, 2025, 19:04 | Insight
Highlights by Sakditad Saowapa from ASCO GU25
The 2025 ASCO Genitourinary Cancers Symposium is currently taking place from February 13-15 at Moscone West in…
Feb 15, 2025, 22:55 | Societies
Highlights From Day 2 of ASCOGU25
The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society of Clinical Oncology…
Feb 15, 2025, 13:30 | Blog
Daniel Heng: The world of antibody-drug conjugates for bladder cancer in clinical trials is amazing
Daniel Heng, Head of Medical Oncology at the Arthur J.E. Child Comprehensive Cancer Centre in…
Feb 10, 2025, 16:11 | Blog
Guru Sonpavde: Take home messages from Puerto Rico Oncology Symposium
Guru Sonpavde, Phase I Clinical Trials Director at Advent Health Central Florida and the Chair…
Feb 8, 2025, 07:02 | Blog
Tom Powles: Bladder cancer highlights at ASCOGU25
Tom Powles, Professor at the University of London and Director of Barts Cancer Centre, shared…
Feb 4, 2025, 16:23 | Blog
Guru Sonpavde: Current therapy and recent advances in bladder cancer treatment at APPOS25
Guru Sonpavde, Phase I Clinical Trials Director at Advent Health Central Florida and the Chair…
Feb 4, 2025, 09:34 | Science
Kristina Jankovic on Urinary DNA methylation test
Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared an article by In…
Feb 3, 2025, 15:23 | Blog
Petros Grivas: Amazing progress in biomarkers on bladder cancer
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Feb 1, 2025, 08:00 | Blog
VI-RADS Scores for Muscle-Invasive Bladder Cancer
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a paper by Giorgio…
Jan 29, 2025, 12:52 | Science
No survival benefit from NAC in bladder cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared an article by Cagri Akpinar et…
Jan 28, 2025, 08:35 | Blog
Andrea Lancia: Speaking at Advanced Uro-Oncology Days on bladder cancer
Andrea Lancia, Radiation Oncologist at Fondazione IRCCS Polilcinico San Matteo, posted the following on LinkedIn: “Delighted…
Jan 27, 2025, 15:58 | Blog
Tom Powles: Bladder sparing approaches after EVP is likely to be the SoC in MIBC
Tom Powles, Professor at the University of London, shared a post on X: "The muscle…
Jan 26, 2025, 15:32 | Insight
Laura Bukavina: A study of 221 patients found no survival benefit from NAC in bladder cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X about a…
Jan 25, 2025, 05:55 | Blog
Registration is open for the "Maximizing Therapeutic Innovations in Bladder Cancer" Symposium - PVI
PVI, PeerView Institute for Medical Education shared a post on LinkedIn: "Join us at the…
Jan 22, 2025, 15:28 | Science
Clinical validation of the Intermediate-risk NMIBC Scoring System and Substratification Model
European Urology Oncology shared an article by Francesco Soria on X: "Clinical Validation of the…
Jan 22, 2025, 10:06 | Science
Shilpa Gupta: Support the Bladder Cancer Advocacy Network 2025 New Faces of Bladderca survey
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, posted on X: "Please support the…
Jan 21, 2025, 16:07 | Insight
Enrique Grande: Intravesical durvalumab shows promise for high-risk NMIBC after BCG failure
Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on LinkedIn…
Jan 19, 2025, 04:45 | Insight
Enrique Grande: Adjuvant Radiation Following Cystectomy
Enrique Grande, Head of Oncology and an Adjunct Professor at the GU Medical Oncology Department…
Jan 18, 2025, 00:00 | Science
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Jan 17, 2025, 09:16 | Insight
Using cDNA testing to guide immunotherapy for Bladder Cancer post-surgery - PRIMR
PRIMR shared a post on X: "New series. Introducing the MODERN Trial: using cDNA testing…
Jan 14, 2025, 16:24 | Insight
Next-generation sequencing and immunotherapy give bladder cancer patient hope
Meleah Foreman celebrated her 70th birthday this past year full of gratitude and hope. "This can…
Jan 12, 2025, 07:12 | Insight
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer
Pfizer Inc. has announced promising topline results from its pivotal Phase 3 CREST trial, which…
Jan 11, 2025, 14:16 | Science
Tom Powles: Positive R3 trial for PD-1 in Non-Muscle Invasive Bladder Cancer
Tom Powles, Professor at the University of London, posted on X: "Big news. A positive…
Jan 6, 2025, 12:15 | Insight
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Erman Akkus, Medical Oncology fellow at Ankara University, Faculty of Medicine, shared a post on…
Jan 4, 2025, 13:16 | Insight
Lars Dyrskjøt: Comprehensive genomic characterization of early-stage bladder cancer
Lars Dyrskjøt, Professor at Aarhus University, shared on X: “I am excited to share our…
Dec 30, 2024, 12:29 | Insight
Laura Bukavina: No significant link was found between plant-based or animal-based protein intake and bladder cancer risk
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X about a…
Dec 29, 2024, 13:42 | Science
The Financial Burden of Localized and Metastatic Bladder Cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, shared…
Dec 28, 2024, 18:09 | Science
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer
European Urology shared a recent article on X: "EAU Guidelines. Editor's Choice: European Association of…
Dec 25, 2024, 22:25 | Insight
Joshua Meeks: Multi-omic T1 analysis for BCG response
Joshua Meeks, Urologic Oncologist and Scientist at Northwestern University, shared a post on X: “Very…
Dec 25, 2024, 14:47 | Science
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on…
Dec 24, 2024, 23:31 | Science
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
A recent paper by Roger Li, Urologic oncologist at Moffitt Cancer Center, was mentioned by…
Dec 24, 2024, 07:56 | Science
Petros Grivas: Excited to see long term follow up of our IMvigor210 trial
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Dec 23, 2024, 13:21 | Insight
Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer
Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…
Dec 22, 2024, 17:23 | Science
Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, posted on X about recent…
Dec 22, 2024, 13:20 | Science
Bladder sparing Therapy for Bacillus unresponsive invasive Bladder Cancer - European Urology
European Urology shared a recent article by Roger Li on X: "Review: Bladder-sparing Therapy for…
Dec 20, 2024, 15:46 | Career
Thomas Powles was awarded the Gordon Hamilton Fairley Medal
Barts Cancer Institute (Queen Mary University of London) shared a post on LinkedIn: “The BCI…
Dec 20, 2024, 12:16 | Science
Laura Bukavina: Microbiome analysis of Fresh Frozen vs FFPE tissue in bladder cancer by Dominik Enderlin et al.
A recent paper by Dominik Enderlin, Urology Resident at the University Hospital of Zurich, published…
Dec 19, 2024, 16:41 | Blog
Survival after trimodal therapy in organ-confined bladder cancer
Enrique Grande, Associate Professor at Francisco de Vitoria University, shared an article by Mattia Longoni…
Dec 19, 2024, 14:08 | Blog
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…
Dec 18, 2024, 06:52 | Blog
Gregory Maes: Representing Nonacus during General Assembly of the ELBS
Gregory Maes, Global Pharma and Strategic Alliances Manager at Nonacus, shared a post on LinkedIn:…
Dec 17, 2024, 23:36 | Blog
Durvalumab and chemotherapy improves survival in MIBC - Uro Today
UroToday.com shared  a post on X: "NIAGARA trial shows durvalumab + chemotherapy improves survival in…
Dec 16, 2024, 17:22 | Blog
Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, posted the following on X: “Such an…
Dec 16, 2024, 08:25 | Science
Laura Bukavina: Higher complications in ileal conduit patients versus neobladder patients
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, posted the…
Dec 14, 2024, 07:33 | Blog
Advancing Treatment Strategies for Muscle-Invasive Bladder Cancer - Mediamedic
Mediamedic shared a post on LinkedIn: "Revolutionizing Muscle-Invasive Bladder Cancer Treatment. At ESMO Asia 2024,…
Dec 8, 2024, 06:30 | Insight
Tom Powles: Cisplatin or Carboplatin-Based Chemotherapy with Pembrolizumab in Advanced Urothelial Cancer
Tom Powles, Director of Barts Cancer Centre, shared a recent article on X: "While EVP…
Dec 8, 2024, 06:29 | Blog
Guru P. Sonpavde: Year in Review 2024 - Bladder Cancer
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared a post on…
Dec 7, 2024, 19:49 | Blog
Tom Powles: Impressive bladder cancer sessions for Asian subsets at ESMO Asia 2024
Tom Powles, The Director of Barts Cancer Centre, a CRUK Major Cancer Centre, posted on…
Dec 7, 2024, 01:55 | Insight
Andrea Necchi: Bladder Preservation vs Radical Cystectomy in Locally Advanced Muscle-Invasive Bladder Cancer
Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a post on X:…
Dec 7, 2024, 01:50 | Blog
Enrique Grande: Honored to participate in ESMO Asia 2024 in Singapore
Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on LinkedIn: "Honored to participate…
Dec 6, 2024, 16:44 | Insight
Emanuele Crupi: Nectin-4 Positivity in GU Malignancies
Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…
Dec 5, 2024, 22:48 | Blog
Enrique Grande: FGFR inhibitors shaping the future of precision medicine
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, posted the following on…
Dec 5, 2024, 01:56 | Blog
Bladder Cancer Advocacy Network’s $300K Research Innovation Award
Bladder Cancer Advocacy Network shared a post on X: "Calling innovators. Have a bold idea…
Dec 3, 2024, 19:10 | Blog
Does the target of enfortumab vedotin play a significant role in the treatment of bladder cancer?
International Urology Cancer Summit shared on X: "Does the target of enfortumab vedotin play a significant…
Dec 3, 2024, 09:45 | Blog
Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL
National Comprehensive Cancer Network shared a post on LinkedIn: "Join us for live symposia this…
Dec 2, 2024, 17:57 | Blog
Petros Grivas: Ananya Choudhury on histology subtypes of Bladder Cancer
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Nov 30, 2024, 23:26 | Insight
Cristiane D Bergerot: Comprehensive care is key in Bladder Cancer
Cristiane D Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared…
Nov 30, 2024, 18:59 | Insight
Paulo G Bergerot: How exercise nutrition and psychosocial support improve outcomes in Cancer care
Cristiane D. Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared…
Nov 29, 2024, 15:54 | Insight
Highlights from BLADDR 2024 by María Natalia Gandur Quiroga
BLADDR 2o24, Second session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU Oncology,…
Nov 29, 2024, 10:54 | Blog
Mieke Van Hemelrijck: "Supporting patients and improving patient communication"
Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, posted on LinkedIn: "Another…
Nov 27, 2024, 11:39 | Immune Oncology
Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More
Immunotherapy has become a transformative approach in treating bladder cancer, utilizing the immune system to…
Nov 26, 2024, 16:42 | Blog
Tian Zhang: STAREV is open and enrolling UTSW Simmons Cancer Center
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…
Nov 25, 2024, 17:42 | Blog
Robot-assisted radical cystectomy vs open radical cystectomy for bladder cancer
Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on X about recent paper…
Nov 24, 2024, 19:20 | Insight
Laura Bukavina: The Urinary and Gut Microbiome role in Bladder Cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, shared…
Nov 24, 2024, 18:04 | Blog
Meet the experts of USANZ 77th Annual Scientific Meeting
USANZ shared a post on X: "Meet the experts- Introducing Dr. Laura Bukavina from Case…
Nov 24, 2024, 13:21 | Blog
Bladder Cancer Updates from the second half of 2024
Danny Burke, CEO at Ecancer, shared a post on LinkedIn: "Join our live broadcast covering…
Nov 15, 2024, 15:10 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Nov 15, 2024, 12:02 | Insight
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "Perioperative Durvalumab with…
Nov 13, 2024, 10:37 | Insight
UCLA: Combination approach shows promise for treating rare, aggressive cancers
UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with…
Nov 12, 2024, 00:31 | Blog
Welcoming Carlos Del Fresno and Marta Dueñas Porta to the next edition of Richi Entrepreneurs
Richi Entrepreneurs shared a post on LinkedIn: " We are excited to welcome Carlos Del Fresno…
Nov 10, 2024, 18:05 | Insight
Update on results of the SWOG Cancer Research Network S1011 trial from the NCI Cancer Currents blog
SWOG Cancer Research Network, shared a post on X: “From NCI Cancer Currents blog, an…
Nov 9, 2024, 19:37 | Blog
Omar Alhalabi: Advancing Knowledge on Aggressive Bladder Cancer Subtypes
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X: “Hot off…
Nov 9, 2024, 16:57 | Insight
The critical role of (p)rehabilitation interventions in the broad management of Bladder Cancer
ACS Journal Cancer shared on X: "A newly published scoping review led by Logan Briggs highlights…
Nov 7, 2024, 00:11 | Blog
Chandler Park's Insights on the SunRISe Program and the Potential of TAR-200 for High-Risk Bladder Cancer
Chandler Park, Kentucky Physician Representative at ASCO State Executive Council, shared a post by Topline Bio on…
All: 280 Posts: 1 - 100
Special Coverage